Highly Pathogenic Avian Influenza: Clinical, Commercial and Community Dynamics

Sponsored by

Educational Objectives

• Understand surveillance targets for H5N1 avian influenza in people, animals and the environment
• Characterize at-risk groups, including vulnerable worker populations, for H5N1 avian influenza exposure and disease
• Describe strategies for control and risk mitigation for H5N1 avian influenza
• To review the need and a strategy for mitigating future respiratory virus pandemic threats
• To review the highly pathogenic H5N1 avian influenza A virus incursions on US Dairy farms
• To improve understanding of the vulnerability of industrial livestock operation workers and factors that influence their ability to speak up and ask questions about risks of HPAI.
• To clarify the structural factors that affect surveillance, testing, and critical hazard information sharing to protect industrial livestock operation workers and neighbors.

Panel Speakers

Gregory C. Gray MD, MPH

Professor in Infectious Disease Epidemiology in the Departments of Internal Medicine (Infectious Diseases), Microbiology & Immunology, Global Health at the University of Texas Medical Branch in Galveston, Texas.

Meghan Davis, DVM MPH PhD

Associate Professor
Department of Environmental Health and Engineering
Johns Hopkins Bloomberg School of Public Health

Christopher D. Heaney, PhD, MS

Associate Professor
Environmental Health & Engineering, Epidemiology (jt), International Health (jt)
Johns Hopkins Bloomberg School of Public Health

Continuing Education Credits

Continuing Nursing Education (CNE)

• This activity has been approved for 1.5 contact hours of Registered Nurse Education by the D.C. Board of Nursing. 
  Course # 20-1258938
  D.C. Board of Nursing Provider # 50-18838 

Continuing Medical Education (CME)

• The AAFP has reviewed Highly Pathogenic Avian Influenza: Clinical, Commercial and Community Dynamics and deemed it acceptable for up to 1.50 Live AAFP Prescribed credits. Activity #106199. 
• AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.